Titan Medical Statistics

Total Valuation

Titan Medical has a market cap or net worth of $4.95 million. The enterprise value is -$5.20 million.

Market Cap	4.95M
Enterprise Value	-5.20M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	0.37%
Float	113.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.50
Forward PS	n/a
PB Ratio	0.71
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.21.

Current Ratio	1.41
Quick Ratio	n/a
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-102.90

Financial Efficiency

Return on equity (ROE) is -99.00% and return on invested capital (ROIC) is -456.12%.

Return on Equity (ROE)	-99.00%
Return on Assets (ROA)	-66.50%
Return on Capital (ROIC)	-456.12%
Revenue Per Employee	$2.50M
Profits Per Employee	-$5.26M
Employee Count	4
Asset Turnover	0.32
Inventory Turnover	n/a

Taxes

In the past 12 months, Titan Medical has paid $56,000 in taxes.

Income Tax	56,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.93% in the last 52 weeks. The beta is 1.98, so Titan Medical's price volatility has been higher than the market average.

Beta (1Y)	1.98
52-Week Price Change	-71.93%
50-Day Moving Average	0.06
200-Day Moving Average	0.09
Relative Strength Index (RSI)	28.73
Average Volume (30 Days)	n/a

Short Selling Information

Short Interest	1.49M
Short Previous Month	132,198
Short % of Shares Out	n/a
Short % of Float	1.31%
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, Titan Medical had revenue of $10.00 million and -$21.04 million in losses. Loss per share was -$0.18.

Revenue	10.00M
Gross Profit	10.00M
Operating Income	-38.47M
Pretax Income	-20.99M
Net Income	-21.04M
EBITDA	-19.93M
EBIT	-20.79M
Loss Per Share	-$0.18

Full Income Statement

Balance Sheet

The company has $11.64 million in cash and $1.48 million in debt, giving a net cash position of $10.16 million.

Cash & Cash Equivalents	11.64M
Total Debt	1.48M
Net Cash	10.16M
Net Cash Per Share	n/a
Equity / Book Value	6.96M
Book Value Per Share	n/a
Working Capital	4.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.97 million and capital expenditures -$511,000, giving a free cash flow of -$32.48 million.

Operating Cash Flow	-31.97M
Capital Expenditures	-511,000
Free Cash Flow	-32.48M
FCF Per Share	-$0.29

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -384.74% and -210.43%.

Gross Margin	100.00%
Operating Margin	-384.74%
Pretax Margin	-209.87%
Profit Margin	-210.43%
EBITDA Margin	-199.26%
EBIT Margin	-207.85%
FCF Margin	-324.82%

Dividends & Yields

Titan Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.48%
Shareholder Yield	-0.48%
Earnings Yield	-425.02%
FCF Yield	-656.07%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on June 19, 2018. It was a reverse split with a ratio of 1:30.

Last Split Date	Jun 19, 2018
Split Type	Reverse
Split Ratio	1:30

Scores

Titan Medical has an Altman Z-Score of -24.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-24.73
Piotroski F-Score	n/a